뉴스벤징가
AstraZeneca Highlights Sustained Survival Benefit In Advanced Breast Cancer Study
· 발표
기사 요약
AstraZeneca reports updated SERENA-6 data showing camizestrant improved PFS, PFS2 and ctDNA clearance in advanced breast cancer.
기사 원문에서 발췌했어요.AstraZeneca reports updated SERENA-6 data showing camizestrant improved PFS, PFS2 and ctDNA clearance in advanced breast cancer.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…